<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Mauduit D</submitter><funding>Kom op tegen Kanker</funding><funding>European Research Council</funding><funding>KU Leuven</funding><funding>Fonds Wetenschappelijk Onderzoek</funding><funding>Stichting tegen Kanker</funding><pagination>e71735</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8691835</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>10</volume><pubmed_abstract>Understanding how enhancers drive cell-type specificity and efficiently identifying them is essential for the development of innovative therapeutic strategies. In melanoma, the melanocytic (MEL) and the mesenchymal-like (MES) states present themselves with different responses to therapy, making the identification of specific enhancers highly relevant. Using massively parallel reporter assays (MPRAs) in a panel of patient-derived melanoma lines (MM lines), we set to identify and decipher melanoma enhancers by first focusing on regions with state-specific H3K27 acetylation close to differentially expressed genes. An in-depth evaluation of those regions was then pursued by investigating the activity of overlapping ATAC-seq peaks along with a full tiling of the acetylated regions with 190 bp s</pubmed_abstract><journal>eLife</journal><pubmed_title>Analysis of long and short enhancers in melanoma cell states.</pubmed_title><pmcid>PMC8691835</pmcid><funding_grant_id>2019-100</funding_grant_id><funding_grant_id>724226_cis-CONTROL</funding_grant_id><funding_grant_id>1S03317N</funding_grant_id><funding_grant_id>C14/18/092</funding_grant_id><funding_grant_id>12J6916N</funding_grant_id><funding_grant_id>724226</funding_grant_id><pubmed_authors>Christiaens V</pubmed_authors><pubmed_authors>Minnoye L</pubmed_authors><pubmed_authors>Hulselmans G</pubmed_authors><pubmed_authors>Demeulemeester J</pubmed_authors><pubmed_authors>Mauduit D</pubmed_authors><pubmed_authors>Aerts S</pubmed_authors><pubmed_authors>de Waegeneer M</pubmed_authors><pubmed_authors>Wouters J</pubmed_authors><pubmed_authors>Taskiran II</pubmed_authors></additional><is_claimable>false</is_claimable><name>Analysis of long and short enhancers in melanoma cell states.</name><description>Understanding how enhancers drive cell-type specificity and efficiently identifying them is essential for the development of innovative therapeutic strategies. In melanoma, the melanocytic (MEL) and the mesenchymal-like (MES) states present themselves with different responses to therapy, making the identification of specific enhancers highly relevant. Using massively parallel reporter assays (MPRAs) in a panel of patient-derived melanoma lines (MM lines), we set to identify and decipher melanoma enhancers by first focusing on regions with state-specific H3K27 acetylation close to differentially expressed genes. An in-depth evaluation of those regions was then pursued by investigating the activity of overlapping ATAC-seq peaks along with a full tiling of the acetylated regions with 190 bp s</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Dec</publication><modification>2026-07-09T12:26:07.467Z</modification><creation>2022-02-11T14:37:03.825Z</creation></dates><accession>S-EPMC8691835</accession><cross_references><pubmed>34874265</pubmed><doi>10.7554/eLife.71735</doi></cross_references></HashMap>